UBS Group
OM icon

UBS Group’s Outset Medical OM Stock Holding History

UBS Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$970K Buy
252,499
+179,339
+245% +$735K ﹤0.01% 5584
2025
Q4 		$271K Buy
73,160
+719
+1% +$6.17K ﹤0.01% 6420
2025
Q3 		$1.02M Sell
72,441
-7,145
-9% -$111K ﹤0.01% 5556
2025
Q2 		$1.53M Buy
79,586
+67,485
+558% +$1.05M ﹤0.01% 5081
2025
Q1 		$134K Buy
12,101
+5,974
+98% +$71.2K ﹤0.01% 6818
2024
Q4 		$102K Buy
6,127
+5,883
+2,411% +$73.4K ﹤0.01% 6862
2024
Q3 		$2.48K Buy
244
+163
+201% +$4.85K ﹤0.01% 8418
2024
Q2 		$4.65K Sell
81
-3,388
-98% -$166K ﹤0.01% 8066
2024
Q1 		$116K Buy
3,469
+2,647
+322% +$134K ﹤0.01% 6157
2023
Q4 		$66.7K Buy
822
+566
+221% +$46.1K ﹤0.01% 6394
2023
Q3 		$41.8K Sell
256
-1,574
-86% -$372K ﹤0.01% 6414
2023
Q2 		$600K Buy
1,830
+67
+4% +$20.4K ﹤0.01% 4671
2023
Q1 		$487K Buy
1,763
+1,465
+492% +$538K ﹤0.01% 4712
2022
Q4 		$115K Buy
298
+16
+6% +$4.51K ﹤0.01% 5967
2022
Q3 		$68K Sell
282
-6,293
-96% -$1.69M ﹤0.01% 6058
2022
Q2 		$1.47M Buy
6,575
+6,475
+6,475% +$2.79M ﹤0.01% 3398
2022
Q1 		$68K Sell
100
-812
-89% -$489K ﹤0.01% 6201
2021
Q4 		$631K Buy
912
+576
+171% +$426K ﹤0.01% 4789
2021
Q3 		$249K Buy
336
+189
+129% +$129K ﹤0.01% 5168
2021
Q2 		$111K Sell
147
-147
-50% -$112K ﹤0.01% 5798
2021
Q1 		$240K Buy
294
+122
+71% +$94.1K ﹤0.01% 5354
2020
Q4 		$146K Buy
172
+136
+378% +$105K ﹤0.01% 5447
2020
Q3 		$27K Buy
+36
New +$29.6K ﹤0.01% 6076

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBS Group's OM Position: Q1 2026 in Review

UBS Group increased its Outset Medical (OM) stake by 245% in Q1 2026, buying an estimated $735K and bringing the position to 252,499 shares worth $970K. The position accounts for ﹤0.01% of the portfolio, ranked #5584.

UBS Group first reported a position in OM in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.53M in Q2 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • UBS Group held 252,499 shares of Outset Medical worth $970K as of Q1 2026.
  • UBS Group bought 179,339 Outset Medical shares in Q1 2026, an estimated $735K.
  • Outset Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5584 holding.
  • UBS Group first reported a position in Outset Medical in Q3 2020 and has held it in 23 quarters since.
  • UBS Group's Outset Medical position peaked at $1.53M in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.